Item 43
approvedMar 27, 2024
Description
Authorize to enter into a no-cost Confidential Disclosure Agreement with Asegua Therapeutics LLC to ensure confidentially of data for discussion, evaluation and negotiation related to Asegua’s product pricing and associated contingencies. Effective upon G&C approval through March 31, 2027.
Department
DEPARTMENT OF CORRECTIONS
Vendor
Asegua Therapeutics LLC
Vote Record
approved
Motion by Kenney, seconded by Warmington acted as follows
Joseph Kenney
(R)
yes
Cinde Warmington
(D)
yes
Janet Stevens
(R)
yes
Ted Gatsas
(R)
yes
Dave Wheeler
(R)
yes